Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Bausch & Lomb Eyetracker Gets FDA Nod

Facebook Twitter LinkedIn Email Comments
ROCHESTER, N.Y., Oct. 18 -- Bausch & Lomb has approval from the US Food and Drug Administration (FDA) to market its Active Eyetracking System in the United States. The eyetracker, which has been commercially available outside the United States since 1994, is a high-speed image processing system that tracks movement of the eye during laser surgery. The new system will be incorporated into all Bausch & Lomb's Technolas 217A excimer lasers sold after November 2001.

The Technolas 217A excimer laser with the Active Eyetracking System calculates both the speed of tracking and overall system reaction time, using its active feedback scanner mechanism, prior to firing the laser pulse. Displacement of laser pulses due to eye movement during surgery can cause a variation in ablation patterns, with the potential for under-correction and induced astigmatism.


Photonics.com
Oct 2001
News & Features

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.